Skip to Primary Navigation

Strategic paths for pharma in a tariff-driven world

A pharmacist works at a pharmacy in Manhattan in New York City.
Photo: Spencer Platt/Getty Images

From short-term moves to long-term manufacturing bets, global reforms are still needed to stabilize the system.

When policy shifts arrive abruptly, the instinct may be to react defensively or wait out the turbulence. The recent wave of US tariffs has sent ripples through a sector already grappling with global dependencies and domestic constraints.

So what can companies do now to adapt swiftly, and what long-term investments